Skp2 is a promising therapeutic target in breast cancer

Skp2 is a promising therapeutic target in breast cancer

Breast cancer is the most common type of cancer among American women, and remains the second leading cause of cancer-related death for female in the United States. It has been known that several signaling pathways and various factors play critical roles in the development and progression of breast c...

Full description

Bibliographic Details
Main Authors: Zhiwei eWang, Hidefumi eFukushima, Hiroyuki eInuzuka, Lixin eWan, Pengda eLiu, Daming eGao, Fazlul H Sarkar, Wenyi eWei
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-01-01
Series:Frontiers in Oncology
Subjects:
Cell Cycle
Ubiquitination
therapy
breast cancer
oncoprotein
signaling pathway
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2011.00057/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2011.00057/full

Similar Items